Global Candidiasis Trials Review Market Analysis Report 2015 Radiant Insights, Inc

Global Candidiasis Trials Review Market Analysis Report 2015:
Radiant Insights, Inc
Summary
GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H1, 2015"" provides an
overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical
trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top
countries conducted across the globe. The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent
drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are
generated using Global Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials
are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.
Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to
gain competitive advantage.
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status,
Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining
to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason
for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business
opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed
and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Candidiasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Candidiasis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Top Companies Participating in Candidiasis Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Astellas Pharma Inc. 37
Clinical Trial Overview of Astellas Pharma Inc. 37
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Basilea Pharmaceutica AG 41
Clinical Trial Overview of Basilea Pharmaceutica AG 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42

Bayer AG 43
Clinical Trial Overview of Bayer AG 43
Laboratory Corporation of America Holdings 44
Clinical Trial Overview of Laboratory Corporation of America Holdings 44
GlaxoSmithKline Plc 45
Clinical Trial Overview of GlaxoSmithKline Plc 45
Durata Therapeutics, Inc. 46
Clinical Trial Overview of Durata Therapeutics, Inc. 46
Bristol-Myers Squibb Company 47
Clinical Trial Overview of Bristol-Myers Squibb Company 47
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Clinical Trial Overview of Top Institutes / Government 48
The National Institute of Allergy and Infectious Diseases 48
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 48
National Cancer Institute 49
Clinical Trial Overview of National Cancer Institute 49
Duke University 50
Clinical Trial Overview of Duke University 50
University Medical Center Groningen 51
Clinical Trial Overview of University Medical Center Groningen 51
Ahvaz Jundishapur University of Medical Sciences 52
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 52
Indian Council of Medical Research 53
Clinical Trial Overview of Indian Council of Medical Research 53
Shahid Beheshti University 54

Clinical Trial Overview of Shahid Beheshti University 54
Shiraz University of Medical Sciences 55
Clinical Trial Overview of Shiraz University of Medical Sciences 55
Tehran University of Medical Sciences 56
Clinical Trial Overview of Tehran University of Medical Sciences 56
The University of Melbourne 57
Clinical Trial Overview of The University of Melbourne 57
Five Key Clinical Profiles 58
Appendix 98
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101
List of Tables
Candidiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Candidiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Candidiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Candidiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Candidiasis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Candidiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Candidiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
37
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 39

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG,
2015* 41
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 42
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 43
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratory Corporation of
America Holdings, 2015* 44
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
45
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Durata Therapeutics, Inc.,
2015* 46
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb
Company, 2015* 47
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of
Allergy and Infectious Diseases, 2015* 48
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute,
2015* 49
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 50
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center
Groningen, 2015* 51
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University
of Medical Sciences, 2015* 52
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical
Research, 2015* 53
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University,
2015* 54
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical
Sciences, 2015* 55
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical
Sciences, 2015* 56

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Melbourne,
2015* 57
List of Figures
Candidiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Candidiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Candidiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Candidiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 99
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-2015
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and individuals procure market research
reports, helping them in the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over extensive database of
reports, our experienced research coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://www.radiantinsightsinc.blogspot.com